These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32769357)

  • 41. Post-match recovery profile of leukocyte cell subsets among professional soccer players.
    Kostrzewa-Nowak D; Wityk P; Ciechanowicz A; Nowak R
    Sci Rep; 2021 Jun; 11(1):13352. PubMed ID: 34172818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evaluations of innate and acquired immune responses to electrospun polydioxanone-elastin blends.
    Smith MJ; White KL; Smith DC; Bowlin GL
    Biomaterials; 2009 Jan; 30(2):149-59. PubMed ID: 18851880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A notch in the toll belt.
    Hertzog P
    Immunity; 2008 Nov; 29(5):663-5. PubMed ID: 19006687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative evaluation of CD52 expression in B-cell chronic lymphocytic leukemia.
    D'Arena G; Vigliotti ML; Matera R; Musto C; Iodice G; Tartarone A; Di Renzo N
    Leuk Lymphoma; 2003 Jul; 44(7):1255-7. PubMed ID: 12916884
    [No Abstract]   [Full Text] [Related]  

  • 47. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
    Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
    Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
    Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
    Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-mediated immunity in chronic lymphocytic leukemia.
    Zent CS
    Leuk Lymphoma; 2010 Oct; 51(10):1775-6. PubMed ID: 20858100
    [No Abstract]   [Full Text] [Related]  

  • 50. T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.
    Szodoray P; Stanford SM; Molberg Ø; Munthe LA; Bottini N; Nakken B
    J Allergy Clin Immunol; 2016 Sep; 138(3):839-851.e8. PubMed ID: 27056269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of human T-lymphocyte antigens by natural killer cells.
    Kaplan J; Callewaert DM
    J Natl Cancer Inst; 1978 May; 60(5):961-4. PubMed ID: 305967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal transducer and activator of transcription 5 tyrosine phosphorylation for the diagnosis and monitoring of patients with severe combined immunodeficiency.
    Walshe D; Gaspar HB; Thrasher AJ; Cale CM; Gilmour KC
    J Allergy Clin Immunol; 2009 Feb; 123(2):505-8. PubMed ID: 19203666
    [No Abstract]   [Full Text] [Related]  

  • 53. Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderly.
    Rider DA; Sinclair AJ; Young SP
    Mech Ageing Dev; 2003 Feb; 124(2):191-8. PubMed ID: 12633939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunology: adaptable innate killers.
    Parham P
    Nature; 2006 May; 441(7092):415-6. PubMed ID: 16724046
    [No Abstract]   [Full Text] [Related]  

  • 55. [Mechanisms of immunotropic effect of the drug composition Taban-Arshan (Tibet medicine) on lymphocytes of patients with early rheumatoid arthritis and atopic bronchial asthma].
    Semenova LIu; Salmasi ZhM; Kazimirskiĭ AN; Poriadin GV
    Patol Fiziol Eksp Ter; 2005; (1):23-5. PubMed ID: 15801236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
    Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
    Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel heterogeneity of the leucocyte common antigen (CD45): disulfide-bound heterodimers between CD45 and an 80 kDa polypeptide.
    Oravecz T; Monostori E; Adrian O; Kurucz E; Andó I
    Immunol Lett; 1994 Apr; 40(1):7-11. PubMed ID: 7523290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T cell-mediated elimination of B7.2 transgenic B cells.
    Fournier S; Rathmell JC; Goodnow CC; Allison JP
    Immunity; 1997 Mar; 6(3):327-39. PubMed ID: 9075933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Linear and adhesive phenotype of tumor lymphocytes and clinical course of chronic leucosis].
    Golenkov AK; Baryshnikov AIu; Mitina TA; Novikov VV
    Vestn Ross Akad Med Nauk; 2005; (5):38-43. PubMed ID: 15960204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bufalin Enhances Immune Responses in Leukemic Mice Through Enhancing Phagocytosis of Macrophage
    Shih YL; Chou JS; Chen YL; Hsueh SC; Chung HY; Lee MH; Chen CP; Lee MZ; Hou HT; Lu HF; Chen KW; Chung JG
    In Vivo; 2018; 32(5):1129-1136. PubMed ID: 30150435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.